Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

246 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study.
Gatault P, Kamar N, Büchler M, Colosio C, Bertrand D, Durrbach A, Albano L, Rivalan J, Le Meur Y, Essig M, Bouvier N, Legendre C, Moulin B, Heng AE, Weestel PF, Sayegh J, Charpentier B, Rostaing L, Thervet E, Lebranchu Y. Gatault P, et al. Among authors: durrbach a. Am J Transplant. 2017 May;17(5):1370-1379. doi: 10.1111/ajt.14109. Epub 2017 Jan 3. Am J Transplant. 2017. PMID: 27862923 Free article. Clinical Trial.
De novo and recurrent diseases: recurrent glomerulopathies.
Charpentier B, Hiesse C, Marchand S, Boubenider S, Durrbach A, Kriaa F. Charpentier B, et al. Among authors: durrbach a. Transplant Proc. 1999 Feb-Mar;31(1-2):264-6. doi: 10.1016/s0041-1345(98)01528-0. Transplant Proc. 1999. PMID: 10083101 No abstract available.
Peripheral blood T cells generated after allogeneic bone marrow transplantation: lower levels of bcl-2 protein and enhanced sensitivity to spontaneous and CD95-mediated apoptosis in vitro. Abrogation of the apoptotic phenotype coincides with the recovery of normal naive/primed T-cell profiles.
Hebib NC, Déas O, Rouleau M, Durrbach A, Charpentier B, Beaujean F, Vernant JP, Senik A. Hebib NC, et al. Among authors: durrbach a. Blood. 1999 Sep 1;94(5):1803-13. Blood. 1999. PMID: 10477707 Free article.
Targeting additional costimulatory pathways: a subtle role for CD2.
Dumont C, Deas O, Hebib C, Durrbach A, Hirsch F, Charpentier B, Senik A. Dumont C, et al. Among authors: durrbach a. Transplant Proc. 2001 Feb-Mar;33(1-2):199-200. doi: 10.1016/s0041-1345(00)01974-6. Transplant Proc. 2001. PMID: 11266778 No abstract available.
Mortality and long term outcome of combined liver and kidney transplantations.
Ammor M, Creput C, Durrbach A, Samuel D, Von Ey F, Hiesse C, Droupy S, Kriaa F, Kreis H, Benoit G, Blanchet P, Bismuth H, Charpentier B. Ammor M, et al. Among authors: durrbach a. Transplant Proc. 2001 Feb-Mar;33(1-2):1179-80. doi: 10.1016/s0041-1345(00)02450-7. Transplant Proc. 2001. PMID: 11267246 No abstract available.
Overview of clinical trials with new agents.
Charpentier B, Hiesse C, Durrbach A, Ammor M, Von Ey F, Kechrid C, Kriaa F. Charpentier B, et al. Among authors: durrbach a. Transplant Proc. 2001 May;33(3):2201-3. doi: 10.1016/s0041-1345(01)01941-8. Transplant Proc. 2001. PMID: 11377502 Review. No abstract available.
246 results